The Weekly Roundup: Advocacy at Work (2.15.19)
Earlier this month, Jessica Astrup Ehret, a pharmacist from our Sterling Pharmacy in Northfield, MN, testified before the Minnesota Senate on a bill that would provide greater oversight of PBMs. The goal is to increase visibility in the supply chain and eliminate PBM self-dealing. Pharmacists’ legislative involvement is critical to the success of measures like this one, according to Tony Post, director of government affairs for Smart-Fill. “Proprietors in independent pharmacy are fighting tooth and nail to make it in this business,” he said. “They need to get active, now, calling legislators and urging passage of bills like this in their states. They have a chance to make a dent.” Most state pharmacy associations have legislative trackers (like this one in Minnesota), or check out this resource to stay on top of legislation in your state and nationally.
Here are a few other stories that might be of interest:
- CMS is considering a proposal that would determine national coverage of FDA-approved CAR-T therapies.
- Oklahoma opioid lawsuit will give the public a detailed first look at arguments that are likely to appear at the broader national suit next fall.
- A recent study has linked flu-like illnesses with an increased risk of stroke.
- February is Heart Health Month. Don’t forget to share the range of resources for patient education that we have available for you.
[Editor’s note:] Our inboxes are stuffed with newsletters and our coffee tables stacked with magazines and industry digests. I’m sure yours are, too. So, we’ve decided to run a weekly sampling of interesting stories, issues coverage, and business ideas we come across each week. We hope you’ll share some of your favorites, too. Drop us a line at email@example.com.
Sign up now to receive the latest independent
pharmacy news, tips, and resources.
This week, Stat News shared coverage of the “unchecked PBM industry” that is currently under scrutiny in New York by pharmacists concerned about spread pricing in the state’s Medicaid program. A Bloomberg analysis of the practice using Medicaid data reviewed the mo...
From blood to sweat and tears, smart technology is changing the way diabetes is monitored and treated. Last spring, a continuous glucose monitor (CGM) that attached to the abdomen was the first of its kind approved by the FDA. Last summer,...